Eupraxia Pharmaceuticals Files 6-K for September 2025
Ticker: EPRX · Form: 6-K · Filed: Sep 2, 2025 · CIK: 1581178
| Field | Detail |
|---|---|
| Company | Eupraxia Pharmaceuticals Inc. (EPRX) |
| Form Type | 6-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, annual-report
TL;DR
Eupraxia Pharma (EPRX) filed a 6-K for Sept 2025, confirming 40-F annual report submission.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 2, 2025, reporting for the month of September 2025. The company, incorporated in Canada and headquartered in Victoria, British Columbia, is a foreign private issuer. This filing indicates they are submitting their annual report under cover of Form 40-F.
Why It Matters
This filing confirms Eupraxia Pharmaceuticals Inc. is a foreign private issuer and is submitting its annual report, which is a standard regulatory disclosure.
Risk Assessment
Risk Level: low — This is a routine regulatory filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Registrant
- 001-41923 (company) — SEC File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (company) — Business Address
- 250-590-3968 (company) — Business Phone
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2025.
What is Eupraxia Pharmaceuticals Inc.'s filing status regarding annual reports?
Eupraxia Pharmaceuticals Inc. is submitting its annual report under cover of Form 40-F.
Where is Eupraxia Pharmaceuticals Inc. located?
The company's principal executive office is located at 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
What is the Commission File Number for Eupraxia Pharmaceuticals Inc.?
The Commission File Number for Eupraxia Pharmaceuticals Inc. is 001-41923.
What is the SIC code for Eupraxia Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Eupraxia Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2025-09-02 08:15:04
Filing Documents
- f6k_090125.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 16KB
- img01.jpg (GRAPHIC) — 14KB
- img02.jpg (GRAPHIC) — 18KB
- 0001171843-25-005662.txt ( ) — 68KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. EUPRAXIA PHARMACEUTICALS INC. Date: September 2, 2025 By: /s/ Alex Rothwell Name: Alex Rothwell Title: Chief Financial Officer